The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type

Extranodal natural killer/T cell lymphoma (ENKL) is a high invasive disease with poor prognosis. Since there is no consensus on standard chemotherapy, we developed an original chemotherapeutic DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen. We retrospectively analyzed 80 pati...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Zhang, Lei, Li, Sucai, Jia, Sisi, Nan, Feifei, Li, Zhaoming, Cao, Jingyu, Fan, Shanshan, Zhang, Chao, Su, Liping, Wang, Jinghua, Xue, Hongwei, Zhang, Mingzhi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295438/
https://ncbi.nlm.nih.gov/pubmed/27517317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11135
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi